FoxM1 is an independent poor prognostic marker and therapeutic target for advanced Middle Eastern breast cancer. [electronic resource]
Publication details: Oncotarget Apr 2018Description: 17466-17482 p. digitalISSN:- 1949-2553
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.